_____________________
Team vector presentation
Schema @nathalie Mignet
The team main interest is on the design of nanomedicine, i.e. nanoparticles for targeted drug delivery or as specific imaging markers. The drug delivery axis covers formulations dedicated to local administration (mucoadhesive liquid/gel forms) and systemic (liposomes, multiple emulsions). The imaging axis aims to follow vectors by optical imaging in small animals, or to design specific probes such as microbubbles for ultrasound or nanoparticle MRI contrast agents. The strength of the team lies in the interdisciplinarity of the personnel which brings together organic chemistry, physicochemistry, pharmacotechnics, and biology (animal experimentation, imaging, tumor models), and their membership of Inserm, CNRS, university and hospital. The team has all the assets in hand to carry out cross-cutting research in the fields of nanomedicine.
Keywords: Functionalized Nanovectors, Pharmacotechnology, Targeting, Particle Imaging Agents, Nanomedicine, Physical Chemistry of Drugs
_____________________
À lire aussi
October 2025 – Thesis defense at UTCBS: Mitta PIERRE
On October 1st, 2025, Mitta PIERRE successfully defended her doctoral thesis entitled “Nanoformulations of antioxidant active ingredients for ophthalmic administration in the prevention of age-related macular degeneration (AMD)” supervised by Pr. Christine CHARRUEAU and co-supervised by Dr. Diana LAMAA
September 2025 – [Keynote research] Nathalie Mignet,Head of Laboratory, Nanomedicines and lipid nanoparticles for nucleic acid delivery
[Keynote research] Nathalie Mignet, Nanomedicines and lipid nanoparticles for nucleic acid delivery
July 2025 – Workshop du master erasmus mundus Nanomed
Workshop du master erasmus mundus Nanomed
June 2025 – Université Paris Cité’s Apprentis Chercheurs conference was held last June, with UTCBS taking part.
Université Paris Cité’s Apprentis Chercheurs conference was held last June, with UTCBS taking part.